Pharmacology, Toxicology and Pharmaceutical Science
Bronchiectasis
100%
Disease
73%
Lung Disease
72%
Atypical Mycobacterium
68%
Infection
66%
Mycobacterium Avium Complex
64%
Atypical Mycobacteriosis
52%
Macrolide
35%
Symptom
32%
Cohort Study
29%
Respiratory Tract Disease
25%
Hepatitis C
25%
Chronic Hepatitis
23%
Antibiotics
22%
Prevalence
21%
Hepatitis C Virus
20%
Pharmacotherapy
19%
Combination Therapy
17%
Virus Hepatitis
17%
Cystic Fibrosis
15%
Chronic Hepatitis B
13%
Hepatitis B Virus
12%
Haemophilus Influenzae Type B
12%
Influenza A (H1N1)
11%
Tolerability
11%
Hepatitis B
11%
Liver Cell Carcinoma
11%
Epidemiology
11%
Antiviral Therapy
11%
Trace Metal
11%
Streptococcus Pneumoniae
11%
Lung Infection
11%
Surface Water
11%
Inactivated Vaccine
11%
HIV
10%
Respiratory Tract Infection
10%
Meningitis
9%
Azithromycin
9%
Ethambutol
9%
Monotherapy
8%
Rifampicin
7%
Rifabutin
7%
Clarithromycin
7%
Mycobacterium abscessus
6%
Influenza Vaccine
6%
Chronic Obstructive Lung Disease
6%
Rifamycin
6%
Antibiotic Therapy
6%
Hemagglutination Inhibiting Antibody
5%
Coughing
5%
Medicine and Dentistry
Bronchiectasis
87%
Disease
80%
Silo-Filler's Disease
69%
Atypical Mycobacterium
56%
Mycobacterium Avium Complex
45%
Symptom
41%
Influenza Vaccination
35%
Infection
34%
Respiratory Disease
34%
Mycobacterium Avium-Intracellulare Infection
32%
Quality of Life
29%
Antibiotic Therapy
19%
Mycobacterium abscessus
19%
Influenza Virus
18%
Prospective Cohort Study
18%
Medicare
17%
Health Care
15%
Seasonal Influenza
14%
Patient Care
14%
Childbirth
13%
Patient-Reported Outcome
13%
Cystic Fibrosis
13%
Morbidity
13%
Prevalence
12%
Fibrosis
12%
Cohort Effect
12%
Drug Therapy
12%
Hepatocellular Carcinoma
11%
Nose Smear
11%
Reverse Transcription
11%
Diagnosis Code
11%
Breast Feeding
11%
Adverse Event
11%
Public Health
11%
Attitude
11%
Likert Scale
11%
Immunoglobulin A Antibody
11%
Prospective Study
11%
Chronic Hepatitis B
11%
Hepatitis C Virus
11%
Rapid Test
11%
Chronic Hepatitis C
11%
Virus Infection
11%
Virogenesis
11%
Cell-Free DNA
11%
Prescription Drug
11%
Focused Ion Beam
11%
Toddlers
11%
Infancy
11%
Health Care Utilization
11%
Keyphrases
Bronchiectasis
76%
Mycobacterium Avium Complex Pulmonary Disease
55%
Mycobacterium Tuberculosis (M. tb)
54%
United States
36%
Mycobacterium Avium Complex
34%
Antibiotic Treatment
33%
Medicare Beneficiaries
24%
Respiratory Symptoms
24%
Chronic Hepatitis Cohort Study
23%
Multidrug
23%
Infectious Diseases Society of America
23%
American Thoracic Society
23%
Macrolides
22%
Nontuberculous Mycobacterial Infection
22%
Health-related Quality of Life
22%
Nontuberculous Mycobacterial Lung Disease
22%
Adverse Events
16%
Guideline-based
16%
Physical Functioning
15%
Immunization
14%
US Medicare
13%
Pulmonary Infection
13%
Treatment Patterns
13%
Clinical Practice Guidelines
12%
Oregon
12%
Specimen Collection
12%
Drug Therapy
12%
Disease Treatment
12%
Patient-Reported Outcomes Measurement Information System (PROMIS)
12%
Azithromycin
12%
Guideline-directed Medical Therapy
12%
Quality of Life
11%
Influenza Incidence
11%
Hepatitis A
11%
Vietnam
11%
Tolerability
11%
Comparative Risk
11%
Emerging Infections
11%
Fibrosis-4 (FIB-4)
11%
Immunoglobulin
11%
Risk Factors
11%
Clarithromycin
11%
Subjective Social Status
11%
Vaccine Promotion
11%
Vaccine Mandates
11%
Hepatitis A Virus
11%
M. Abscessus Complex
11%
Detection Test
11%
Winter Season
11%
HIV Patients
11%